Next generation gold drugs and probes: chemistry and biomedical applications

RT Mertens, S Gukathasan, AS Arojojoye… - Chemical …, 2023 - ACS Publications
The gold drugs, gold sodium thiomalate (Myocrisin), aurothioglucose (Solganal), and the
orally administered auranofin (Ridaura), are utilized in modern medicine for the treatment of …

Inhibition of glycolysis and glutaminolysis: an emerging drug discovery approach to combat cancer

NS Akins, TC Nielson, HV Le - Current topics in medicinal …, 2018 - ingentaconnect.com
Cancer cells have a very different metabolism from that of normal cells from which they are
derived. Their metabolism is elevated, which allows them to sustain higher proliferative rate …

[HTML][HTML] Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer

T Liu, X Zhang, L Du, Y Wang, X Liu, H Tian, L Wang… - Molecular cancer, 2019 - Springer
Background Oxaliplatin resistance is a major challenge for treatment of advanced colorectal
cancer (CRC). Both acquisition of epithelial-mesenchymal transition (EMT) and suppressed …

Oxaliplatin: a review in the era of molecularly targeted therapy

T Alcindor, N Beauger - Current oncology, 2011 - mdpi.com
Objective: To review preclinical and clinical data for oxaliplatin in the current context of
molecularly targeted therapy. Methods of Study Selection: We searched the PubMed and …

[HTML][HTML] The role of p53 dysfunction in colorectal cancer and its implication for therapy

M Michel, L Kaps, A Maderer, PR Galle, M Moehler - Cancers, 2021 - mdpi.com
Simple Summary Despite remarkable progress being made by preventive medical check-
ups in the last decades, colorectal cancer (CRC) remains one of the most frequent and …

[HTML][HTML] Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN)

A Canta, E Pozzi, VA Carozzi - Toxics, 2015 - mdpi.com
The mitochondrial dysfunction has a critical role in several disorders including
chemotherapy-induced peripheral neuropathies (CIPN). This is due to a related …

Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights

AA Farooqi, M De La Roche, MBA Djamgoz… - Seminars in cancer …, 2019 - Elsevier
Colorectal cancer is a multifaceted disease which is therapeutically challenging. Based on
insights gleaned from almost a quarter century of research, it is obvious that deregulation of …

[HTML][HTML] Platinum complexes in colorectal cancer and other solid tumors

B Köberle, S Schoch - Cancers, 2021 - mdpi.com
Simple Summary Cisplatin is successfully used for the treatment of various solid cancers.
Unfortunately, it shows no activity in colorectal cancer. The resistance phenotype of …

Predictive and prognostic molecular markers for cancer medicine

S Mehta, A Shelling, A Muthukaruppan… - … in medical oncology, 2010 - journals.sagepub.com
Over the last 10 years there has been an explosion of information about the molecular
biology of cancer. A challenge in oncology is to translate this information into advances in …

[HTML][HTML] PEGylated chitosan nanoparticles encapsulating ascorbic acid and oxaliplatin exhibit dramatic apoptotic effects against breast cancer cells

SA Fahmy, A Ramzy, AA Mandour, S Nasr… - Pharmaceutics, 2022 - mdpi.com
This study aims to design a pH-responsive dual-loaded nanosystem based on PEGylated
chitosan nanoparticles loaded with ascorbic acid (AA) and oxaliplatin (OX) for the effective …